术前无创检查评估肝脏储备功能在肝癌治疗中的应用进展
Preoperative Non-Invasive Examination to Evaluate the Application of Liver Reserve Function in the Treatment of Liver Cancer
DOI: 10.12677/ACM.2023.13102196, PDF,   
作者: 费发珠:青海大学临床医学院,青海 西宁;任 宾*:青海大学附属医院肝胆胰外科,青海 西宁
关键词: 肝肿瘤肝功能储备预后综述Liver Neoplasms Liver Functional Reserve Prognosis Review
摘要: 肝癌是我国第4位常见恶性肿瘤,其治疗首选肝切除术,而术后肝功能衰竭(PHLF)是肝癌术后发生重大并发症及患者死亡的重要原因,目前其临床发生率仍很高,因此术前准确评估患者肝脏储备功能对预防PHLF至关重要。传统评估术前肝功能储备方法(如:Child评分、CT等)对存在不同肝病基础的患者准确度欠佳,而无创检查由于创伤小,并发症少受到临床重视,近些年临床应用的吲哚菁绿(ICG)检查、肝弹性成像,三维重建技术、残肝体积计算及核医学等功能学显像技术能同时对术后残余肝体积(RLV)和残余肝功能进行评估,较传统评估方法更具优势。
Abstract: Liver Neoplasms is the fourth common malignant tumor in China, and its treatment is preferred by hepatectomy, but postoperative liver failure (PHLF) is an important cause of major complications and death of patients after liver cancer surgery, and its clinical incidence is still very high, so accu-rate assessment of liver reserve function in patients before surgery is very important to prevent PHLF. Traditional methods for assessing preoperative liver function reserve (such as Child score, CT, etc.) are not accurate for patients with different liver disease bases, while non-invasive examination has received little clinical attention due to small trauma and complications, and in recent years, the clinical application of indocyanine green (ICG) examination, liver elasticity imaging techniques, three-dimensional reconstruction technology, residual liver volume calculation and nuclear medi-cine and other functional imaging techniques can evaluate the residual liver volume (RLV) and re-sidual liver function at the same time, which has more advantages than traditional assessment methods.
文章引用:费发珠, 任宾. 术前无创检查评估肝脏储备功能在肝癌治疗中的应用进展[J]. 临床医学进展, 2023, 13(10): 15701-15709. https://doi.org/10.12677/ACM.2023.13102196

参考文献

[1] Llovet, J.M., Kelley, R.K., Villanueva, A., et al. (2021) Hepatocellular Carcinoma. Nature Reviews Disease Primers, 7, Article No. 6. [Google Scholar] [CrossRef] [PubMed]
[2] 中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗指南(2022年版) [J]. 中华肝脏病杂志, 2022, 30(4): 367-388.
[3] Huang, D.Q., El-Serag, H.B. and Loomba, R. (2021) Global Epidemiology of NAFLD-Related HCC: Trends, Predictions, Risk Factors and Preven-tion. Nature Reviews Gastroenterology & Hepatology, 18, 223-238. [Google Scholar] [CrossRef] [PubMed]
[4] Van Den Broek, M.A.J., Olde Damink, S.W.M., Dejong, C.H.C., et al. (2008) Liver Failure after Partial Hepatic Resection: Definition, Pathophysiology, Risk Factors and Treat-ment. Liver International, 28, 767-780. [Google Scholar] [CrossRef] [PubMed]
[5] Shoup, M., Gonen, M., D’Angelica, M., et al. (2003) Volumetric Analysis Predicts Hepatic Dysfunction in Patients Undergoing Major Liver Resection. Journal of Gastroin-testinal Surgery, 7, 325-330. [Google Scholar] [CrossRef
[6] Lin, X.J., Yang, J., Chen, X.B., et al. (2014) The Critical Value of Remnant Liver Volume-to-Body Weight Ratio to Estimate Posthepatectomy Liver Failure in Cirrhotic Patients. Journal of Surgical Research, 188, 489-495. [Google Scholar] [CrossRef] [PubMed]
[7] Laurent, C., Sa Cunha, A., Couderc, P., et al. (2003) Influence of Postoperative Morbidity on Long-Term Survival Following Liver Resection for Colorectal Metastases. British Journal of Surgery, 90, 1131-1136. [Google Scholar] [CrossRef] [PubMed]
[8] 谢浩荣, 王恺, 周杰. 白蛋白-胆红素评分与Child-Pugh评分预测肝癌患者术后肝功能衰竭的效果比较[J]. 中华肝胆外科杂志, 2018, 24(3): 173-178.
[9] Wong, W.G., Perez Holguin, R.A., Tarren, A.Y., et al. (2022) Albumin-Bilirubin Score Is Superior to Platelet-Albumin- Bilirubin Score and Model for End-State Liver Disease Sodium for Predicting Posthepatectomy Liver Failure. Journal of Surgical Oncology, 126, 667-679. [Google Scholar] [CrossRef] [PubMed]
[10] Garcea, G., Ong, S.L. and Maddern, G.J. (2009) Predicting Liver Failure Following Major Hepatectomy. Digestive and Liver Disease, 41, 798-806. [Google Scholar] [CrossRef] [PubMed]
[11] Forner, A., Reig, M.E., de Lope, C.R., et al. (2010) Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects. Seminars in Liver Disease, 30, 61-74. [Google Scholar] [CrossRef] [PubMed]
[12] Kudo, M., Chung, H. and Osaki, Y. (2003) Prognostic Staging Sys-tem for Hepatocellular Carcinoma (CLIP Score): Its Value and Limitations, and a Proposal for a New Staging System, the Japan Integrated Staging Score (JIS Score). Journal of Gastroenterology, 38, 207-215. [Google Scholar] [CrossRef] [PubMed]
[13] Kitai, S., Kudo, M., Minami, Y., et al. (2008) Validation of a New Prognostic Staging System for Hepatocellular Carcinoma: A Comparison of the Biomarker-Combined Japan Integrated Staging Score, the Conventional Japan Integrated Staging Score and the BALAD Score. Oncology, 75, 83-90. [Google Scholar] [CrossRef] [PubMed]
[14] Bruix, J., Cheng, A.L., Meinhardt, G., et al. (2017) Prognostic Factors and Predictors of Sorafenib Benefit in Patients with Hepatocellular Carcinoma: Analysis of Two Phase III Studies. Journal of Hepatology, 67, 999-1008. [Google Scholar] [CrossRef] [PubMed]
[15] Cescon, M., Cucchetti, A., Grazi, G.L., et al. (2009) Indication of the Extent of Hepatectomy for Hepatocellular Carcinoma on Cirrhosis by a Simple Algorithm Based on Preoperative Variables. The Archives of Surgery, 144, 57-63. [Google Scholar] [CrossRef] [PubMed]
[16] Kamath, P.S., Wiesner, R.H., Malinchoc, M., et al. (2001) A Mod-el to Predict Survival in Patients with End-Stage Liver Disease. Hepatology, 33, 464-470. [Google Scholar] [CrossRef] [PubMed]
[17] Ross Samuel, W., Seshadri, R., Walters, A.L., et al. (2016) Mortality in Hepatectomy: Model for End-Stage Liver Disease as a Predictor of Death Using the National Surgical Quality Im-provement Program Database. Surgery, 159, 777-792. [Google Scholar] [CrossRef] [PubMed]
[18] Brown, C., Aksan, N. and Muir, A.J. (2022) MELD-Na Accurately Predicts 6-Month Mortality in Patients with Decompensated Cirrhosis: Potential Trigger for Hospice Referral. Journal of Clinical Gastroenterology, 56, 902-907. [Google Scholar] [CrossRef
[19] Natkha, V.P., Southerland, P., Almekdash, M.H., et al. (2023) Predicting Outcomes in Trauma Patients with Cirrhosis Using Model for End-Stage Liver Disease Score: A Ret-rospective Study. The American Surgeon, 89, 2383-2390. [Google Scholar] [CrossRef] [PubMed]
[20] De Gasperi, A., Mazza, E. and Prosperi, M. (2016) Indocyanine Green Kinetics to Assess Liver Function: Ready for a Clinical Dynamic Assessment in Major Liver Surgery? World Journal of Hepatology, 8, 355-367. [Google Scholar] [CrossRef] [PubMed]
[21] Kokudo, N. and Makuuchi, M. (2009) Evidence-Based Clinical Practice Guidelines for Hepatocellular Carcinoma in Japan: The J-HCC Guidelines. Journal of Gastroenterology, 44, 119-121. [Google Scholar] [CrossRef] [PubMed]
[22] Greco, E., Nanji, S., Bromberg, I.L., et al. (2011) Predictors of Peri-Opertative Morbidity and Liver Dysfunction after Hepatic Resection in Patients with Chronic Liver Disease. HPB (Oxford), 13, 559-565. [Google Scholar] [CrossRef] [PubMed]
[23] Imamura, H., Seyama, Y., Kokudo, N., et al. (2003) One Thousand Fifty-Six Hepatectomies without Mortality in 8 Years. The Archives of Surgery, 138, 1198-1206. [Google Scholar] [CrossRef] [PubMed]
[24] Seyama, Y. and Kokudo, N. (2009) Assessment of Liver Func-tion for Safe Hepatic Resection. Hepatology Research, 39, 107-116. [Google Scholar] [CrossRef
[25] Lee, C.F., Yu, M.C., Kuo, L.M., et al. (2007) Using In-docyanine Green Test to Avoid Post-Hepatectomy Liver Dysfunction. Chang Gung Medical Journal, 30, 333-338.
[26] Kim, H.J., Kim, C.Y., Park, E.K., Hur, Y.H., Koh, Y.S., et al. (2015) Volumetric Analysis and Indocya-nine Green Retention Rate at 15 Min as Predictors of Post-Hepatectomy Liver Failure. HPB, 17, 159-167. [Google Scholar] [CrossRef] [PubMed]
[27] Vos, J.J., Wietasch, J.K., Absalom, A.R., et al. (2014) Green Light for Liver Function Monitoring Using Indocyanine Green? An Overview of Current Clinical Applications. Anaesthesia, 69, 1364-1376. [Google Scholar] [CrossRef] [PubMed]
[28] 董家鸿, 郑树森, 陈孝平, 等. 肝切除术前肝脏储备功能评估的专家共识(2011版) [J]. 中华消化外科杂志, 2011, 10(1): 20-25.
[29] Martínez, S.M., Crespo, G., Navasa, M., et al. (2011) Noninvasive Assessment of Liver Fibrosis. Hepatology, 53, 325- 335. [Google Scholar] [CrossRef] [PubMed]
[30] Wong, G.L., Chan, H.L., Wong, C.K., et al. (2014) Liver Stiffness-Based Optimization of Hepatocellular Carcinoma Risk Score in Patients with Chronic Hepatitis B. Journal of Hepatology, 60, 339-345. [Google Scholar] [CrossRef] [PubMed]
[31] Lee, H.W., Yoo, E.J., Kim, B.K., et al. (2014) Prediction of De-velopment of Liver-Related Events by Transient Elastography in Hepatitis B Patients with Complete Virological Re-sponse on Antiviral Therapy. The American Journal of Gastroenterology, 109, 1241-1249. [Google Scholar] [CrossRef] [PubMed]
[32] Paefgen, V., Doleschel, D. and Kiessling, F. (2015) Evolution of Con-trast Agents for Ultrasound Imaging and Ultrasound-Mediated Drug Delivery. Frontiers in Pharmacology, 15, Article No. 197. [Google Scholar] [CrossRef] [PubMed]
[33] Chernyak, V., Fowler, K.J., Kamaya, A., et al. (2018) Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients. Radi-ology, 289, 816-830. [Google Scholar] [CrossRef] [PubMed]
[34] Zheng, S.G., Xu, H.X. and Liu, L.N. (2014) Management of Hepatocellular Carcinoma: The Role of Contrast-Enhanced Ultrasound. World Journal of Radiology, 6, 7-14. [Google Scholar] [CrossRef] [PubMed]
[35] Cho, K., Wang, X., Nie, S., et al. (2018) Therapeutic Nanoparticles for Drug Delivery in Cancer. Clinical Cancer Research, 14, 1310-1316. [Google Scholar] [CrossRef
[36] Go, Y., Lee, H., Jeong, L., et al. (2018) Acid-Triggered Echogenic Nanoparticles for Contrast-Enhanced Ultrasound Imaging and Therapy of Acute Liver Failure. Biomaterials, 186, 22-30. [Google Scholar] [CrossRef] [PubMed]
[37] Capussotti, L., Muratore, A., Amisano, M., et al. (2006) Liver Resection for Large-Size Hepatocellular Carcinomas in 47 Non-Cirrhotic Patients—No Mortality and Long-Term Survival. Hepatogastroenterology, 53, 768-772.
[38] Tu, R., Xia, L.-P., Yu, A.-L., et al. (2007) Assessment of Hepatic Functional Reserve by Cirrhosis Grading and Liver Volume Measurement Using CT. World Journal of Gastroenterolo-gy, 13, 3956-3961. [Google Scholar] [CrossRef] [PubMed]
[39] Bogner, A., Reissfelder, C., Striebel, F., et al. (2021) Intraoperative Increase of Portal Venous Pressure Is an Immediate Predictor of Posthepatectomy Liver Failure after Major Hepatectomy: A Prospective Study. Annals of Surgery, 274, e10-e17. [Google Scholar] [CrossRef
[40] Ghibellini, G., Leslie, E.M., Pollack, G.M., et al. (2008) Use of tc-99m Mebrofenin as a Clinical Probe to Assess Altered Hepatobiliary Transport: Integration of in Vitro, Pharmaco-kinetic Modeling, and Simulation Studies. Pharmaceutical Research, 25, 1851-1860. [Google Scholar] [CrossRef] [PubMed]
[41] Liu, X., Jiang, H., Chen, J., et al. (2017) Gadoxetic Acid Diso-dium-Enhanced Magnetic Resonance Imaging Outperformed Multidetector Computed Tomography in Diagnosing Small Hepatocellular Carcinoma: A Meta-Analysis. Liver Transplantation, 23, 1505-1518. [Google Scholar] [CrossRef] [PubMed]
[42] Rassam, F., Zhang, T., Cieslak, K.P., et al. (2019) Comparison between Dy-namic Gadoxetate-Enhanced MRI and 99mTc-Mebrofenin Hepatobiliary Scintigraphy with SPECT for Quantitative As-sessment of Liver Function. European Radiology, 29, 5063-5072. [Google Scholar] [CrossRef] [PubMed]
[43] Erdogan, D., Heijnen, B.H.M., Bennink, R.J., et al. (2004) Pre-operative Assessment of Liver Function: A Comparison of 99mTc-Mebrofenin Scintigraphy with Indocyanine Green Clearance Test. Liver International, 24, 117-123. [Google Scholar] [CrossRef] [PubMed]
[44] Chang, C.C., Huang, H.C., Liu, K., et al. (2016) Clinical Feasibility of GD-EOB-DTPA Enhanced MR Imaging for Assessing Liver Function: Validation with ICG Tests and Parenchymal Cell Volume. Clinical Imaging, 40, 797-800. [Google Scholar] [CrossRef] [PubMed]
[45] Araki, K., Harimoto, N., Yamanaka, T., et al. (2020) Efficiency of Regional Functional Liver Volume Assessment Using GD-EOB-DTPA-Enhanced Magnetic Resonance Imaging for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Surgery Today, 50, 1496-1506. [Google Scholar] [CrossRef] [PubMed]
[46] de Graaf, W., van Lienden, K.P., van Gulik, T.M., et al. (2010) (99m)Tc-mebrofenin Hepatobiliary Scintigraphy with SPECT for the Assessment of Hepatic Function and Liver Func-tional Volume before Partial Hepatectomy. Journal of Nuclear Medicine, 51, 229-236. [Google Scholar] [CrossRef] [PubMed]
[47] Nanashima, A., Abo, T., Kudo, T., et al. (2013) Usefulness of Examining Hepatic Functional Volume Using Technetium-99m Galactosyl Serum Albumin Scintigraphy in Hepatocellu-lar Carcinoma. Nuclear Medicine Communications, 34, 478-488. [Google Scholar] [CrossRef
[48] Sugai, Y., Komatani, A., Hosoya, T., et al. (2000) Re-sponse to Percutaneous Transhepatic Portal Embolization: New Proposed Parameters by99mTc-GSA SPECT and Their Usefulness in Prognostic Estimation after Hepatectomy. Journal of Nuclear Medicine, 41, 421-425.
[49] Kaibori, M., Ha-Kawa, S.K., Ishizaki, M., et al. (2008) HA/GSA-Rmaxratio as a Predictor of Postoperative Liver Failure. World Journal of Surgery, 32, 2410-2418. [Google Scholar] [CrossRef] [PubMed]